IOT-022

N/A

Report date: 2022/07/06 13:54:40
NME

Base Information

Drug NameIOT-022
Drug Alias NameIOT-022
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBile acid receptor FXR agonists
TargetsBile acid receptor FXR
Therapy Area/IndicationsFatty Liver
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInorbit Therapeutics AB
China Registration ClassN/A

Develop Information

Active CompaniesInorbit Therapeutics AB
Inactive CompaniesN/A
Active IndicationsFatty Liver
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A